NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Day-time abstention may help combat obesity
Fri May 18th - Regular eating times and fasting for a number of hours a day might prove to be beneficial to our health, a US study has claimed. More
Conflict over diet advice for pregnant women
Fri May 18th - Pregnant women can reduce the risk of developing serious complications by following a calorie controlled diet, researchers say today. More
Athlete pain tolerance could aid treatment
Fri May 18th - Athletes’ ability to tolerate pain for longer than non-athletes could give pain management specialists new ways of treating patients, researchers reported yesterday. More
RECENT COMMENTS
On 11/05/2012 Anonymous wrote:
In fact the biggest risk is the patch and the ring - Read more

On 10/05/2012 Editor wrote:
Welcome to Englemed comments. We'd like your view - Read more

THIS WEEK'S STORIES
New heart medicine drive
Thurs May 17th - People with high cholesterol are being encouraged to take their medicines today as research highlighted the benefits of the medicines. More
Nine new breast cancer genes
Thurs May 17th - Nine new genes have been found linked to breast cancer, British scientists revealed last night. More
Poor food tax plan probed
Wed May 16th - Fatty foods would need a "fat tax" of at least 20 per cent to make a significant difference to the way Britons eat, experts warn today. More
Extra time drug u-turn
Wed May 16th - British regulators today performed a u-turn over a controversial drug - which campaigners say can give men with prostate cancer quality "extra time". More
ENGLEMED HEALTH NEWS

Multiple medications new risk for elderly

Friday June 24th, 2011

Elderly people may be unwittingly overdosing on drugs, leading to dementia and death, researchers warned today.

Taking too many of the drugs, which are used for treating pain, asthma and the heart, may treble the risk of dying, according to the study conducted by two universities in East Anglia, UK.

The research involves drugs with what are known as anticholinergic and these include common pain-killers such as Codeine and antihistamines such as Chlorphenamine.

Anti-depressants, tranquilisers, bladder medication and some drugs for glaucoma and epilepsy may all have this effect.

An analysis of more than 13,000 people over the age of 65 found that 20 per cent died within two years if they were taking large doses of these drugs. This compared with seven per cent of those taking none of them.

The researchers say many patients may end up being prescribed anticholinergics for multiple conditions.

Researcher Professor Carol Brayne, of Cambridge University, UK, said: “It is important to scrutinise medications given to older people very carefully to try to minimise harm as well as gain the desired benefit.

"The admirable wish to give the best possible treatment with good evidence for individual conditions has to be balanced against the fact that in many older people with multiple conditions this will lead to accumulated risk such as that shown by this scale.”

Fellow researcher Dr Chris Fox, of the University of East Anglia, UK, said: “This is the first large scale study into the long-term impact of medicines which block acetylcholine - a common brain neurotransmitter - on humans, and our results show a potentially serious effect on mortality.

"Clinicians should conduct regular reviews of the medication taken by their older patients, both prescribed and over the counter, and wherever possible avoid prescribing multiple drugs with anticholinergic effects."

Dr Susanne Sorensen, of the UK's Alzheimer’s Society, said: "This robust study provides valuable findings, and must be taken seriously. However it is vital that people do not panic or stop taking their medication without consulting their GP.

We would urge people to have regular appointments with their doctor to review all drug treatments they are taking. This will help ensure they are on the best medications for their conditions, and that any side effects have been taken into consideration.”

* The researchers say the groups with the greatest impact include: anti-depressants such as Amitriptyline, Imipramine and Clomipramine; tranquilisers such as Chlorpromazine and Trifluoperazine; bladder medication such as Oxybutynin; and antihistamines such as Chlorphenamine.

Other drugs with an anticholinergic effect include: Atenolol, Furosemide and Nifedipine for heart problems; painkillers such as Codeine and Dextropropoxyphene; the asthma treatment Beclometasone; the epilepsy treatment Carbamazepine; and Timolol eyedrops which are used for glaucoma.

Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study (CFAS). C Fox (UEA), K Richardson (University of Cambridge), I Maidment (Kent and Medway NHS and Social Care Partnership Trust), G Savva (University of Cambridge), F Matthews (MRC Biostatistics Unit), D Smithard (Kent Community Health NHS Trust), S Coulton (University of Kent), C Katona (University College London), M Boustani (Indiana University), and C Brayne (University of Cambridge). Journal of the American Geriatrics Society June 24 2011.

Tags: Brain & Neurology | Elderly Health | North America | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

CATEGORIES